Specialty focus Target health systems and clinics that manage chronic and complex diseases, offering City Drugs as a provider of patient-centric specialty pharmacy services with programs and tools designed to improve outcomes in inflammatory diseases, transplant, hepatitis C, oncology, and autoimmune conditions.

Private and local Leverage City Drugs’ private ownership and New York base to pursue regional hospital networks and multisite clinics seeking agile, relationship-driven specialty pharmacy partners with compliant multi-state licensing.

Technology edge Position City Drugs’ patient support programs and technology tools as differentiators to boost adherence, coordination, and outcomes, highlighting capabilities that integrate with provider workflows and patient management.

Growth opportunities Explore partnerships with mid to large ambulatory care centers and specialty clinics expanding in chronic disease management, offering scalable programs and cost-effective dispensing for high-need patient populations.

Competitive positioning Emphasize lean, patient-centric service and multi-state licensing to compete for niche chronic disease segments against larger chains, GoodRx-like platforms, and regional specialty pharmacies seeking enhanced clinical support.